Quantum BioPharma is at the forefront of biotechnology, committed to advancing scientific innovation and transforming lives. Our groundbreaking research is dedicated to the development of life-saving treatments for neurodegenerative diseases, with a focus on Multiple Sclerosis (MS). Through our unwavering commitment to excellence, we are pioneering the development of Lucid-MS, a potential therapeutic aimed at remyelinating neurons in the brain and spinal cord. Our vision is to restore abilities and improve the quality of life for those affected by MS.
As we advance our compounds through rigorous preclinical and clinical phases, we remain steadfast in our mission to turn scientific breakthroughs into reality. Join us in our pursuit of a brighter, healthier future, where innovation meets hope, and science saves lives.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 55 University Ave, Toronto,ontario M5j 2h7,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- fsdpharma.com
- HQ
- Toronto, Ontario
Quantum Biopharma (Nasdaq: $qntm) Questions
Quantum Biopharma (Nasdaq: $Qntm)'s website is fsdpharma.com
Quantum Biopharma (Nasdaq: $Qntm)'s LinkedIn profile is https://ca.linkedin.com/company/quantumbiopharma
Quantum Biopharma (Nasdaq: $Qntm) has
11 employees.
View email and phone details for 11
employees at Quantum Biopharma (Nasdaq: $Qntm).
Quantum Biopharma (Nasdaq: $Qntm)'s industry is
Pharmaceutical Manufacturing
Quantum Biopharma (Nasdaq: $Qntm)'s top competitors are
Lucid Psycheceuticals Inc.,
Promis™ Neurosciences, Inc.,
Aptamers- Neoventures Biotechnology Inc.,
Tetra Bio-Pharma,
Nervgen Pharma Corp.,
Diamond Therapeutics,
Unbuzzd Wellness Inc.,
Tiziana Life Sciences,
Arrivo Bio,
Fsd Pharma Inc..
Quantum Biopharma (Nasdaq: $Qntm)'s categories are Pharmaceutical Manufacturing
Quantum Biopharma (Nasdaq: $Qntm)'s founding year is 2024
